Summary Stage 2018: Skin Eyelid
Summary Stage 2018
Notes
**Skin Eyelid**
8000-8040, 8042-8180, 8191-8246, 8248-8700, 8940-8941, 8980
C441
C441 Eyelid
**Note 1:** The following sources were used in the development of this chapter
* SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)
* SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/)
* Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx
* Chapter 64 *Eyelid Carcinoma*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.
**Note 2:** See the following chapters for the listed histologies
* 8041, 8190, 8247: *Merkel Cell Skin*
* 8710-8714, 8800-8934, 8950-8975, 8981-9137, 9141-9514, 9520-9582: *Soft Tissue*
* 8720-8790: *Melanoma Skin*
* 8935-8936: *GIST*
* 9140: *Kaposi Sarcoma*
* 9700-9701: *Mycosis Fungoides*
**Note 3:** Code the tumor with the greatest extension when there are multiple simultaneous tumors.
**Note 4:** Full eyelid thickness (code 1) is defined as including skin, orbicularis muscle, tarsus and conjunctiva (palpebral).
SS2018 |
Description |
0 |
In situ, intraepithelial, noninvasive
- Bowen disease |
1 |
Localized only (localized, NOS)
- Eyelid margin
- Full thickness of eyelid
- Lesion(s) confined to dermis
- Minimal infiltration of dermis
- Subcutaneous tissue (through entire dermis)
- Underlying orbicularis muscle
- Tarsal plate
- Tarsus |
2 |
Regional by direct extension only
- Adjacent structures, NOS
- Bone/periosteum of orbit
- Bony walls of orbit (invades or evades through)
- Bulbar conjunctiva
- Intraorbital structures, NOS
- Lacrimal sac
- Ocular structures
- Sclera
- Skeletal muscles (except orbicularis muscle of eyelid)
- Soft tissues of orbit
- Underlying cartilage |
3 |
Regional lymph node(s) involved only
- Buccinator (buccal)
- Cervical, NOS
- Facial, NOS
- Intraparotid
- Nasolabial
- Parotid
+ Infra-auricular
+ Preauricular
- Submandibular [submaxillary]
- Submental
- Supraclavicular, NOS
- Regional lymph node(s), NOS
+ Lymph node(s), NOS |
4 |
Regional by BOTH direct extension AND regional lymph node(s) involved
- Codes (2) + (3) |
7 |
Distant site(s)/lymph node(s) involved
- Distant site(s) (including further contiguous extension)
+ Brain
+ Central nervous system (CNS)
+ Nasal cavity
+ Nasolacrimal duct
+ Other craniofacial structures
+ Paranasal sinus
- Distant lymph node(s), NOS
- Distant metastasis, NOS
+ Carcinomatosis
+ Distant metastasis WITH or WITHOUT distant lymph node(s), NOS
+ Metastatic skin lesions with or without distant lymph node(s) |
9 |
Unknown if extension or metastasis |
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998
(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.
(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL)
(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30
(5) Esmaeli, B., Finger, P.T., et al. **Eyelid Carcinoma**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 779-785